Literature DB >> 26971627

Oxidative stress and glyoxalase I activity mediate dicarbonyl toxicity in MCF-7 mamma carcinoma cells and a tamoxifen resistant derivative.

Norbert Nass1, Saadettin Sel2, Atanas Ignatov3, Albert Roessner4, Thomas Kalinski4.   

Abstract

BACKGROUND: Acquired tamoxifen resistance is a significant problem in estrogen receptor positive breast cancer. In a cellular model, tamoxifen resistance was associated with increased sensitivity towards toxic dicarbonyls and reduced free sulfhydryl group content. We here analyzed the role of oxidative stress and glyoxalase I activity on dicarbonyl resistance and the significance of glyoxalase I expression for survival.
METHODS: Reactive oxygen species were determined by 2,7-dihydrochlorofluorescein diacetate. Inhibitors for NADPH-oxidase (diphenyleneiodonium), p38 MAPK (SB203580) and ERK1/2 (UO126) were applied to investigate interactions of these signaling molecules. N-acetyl cysteine was used to evaluate the effect of oxidative stress on cell viability, which was assessed by the resazurin assay. Gene expression was analyzed by real time qRT-PCR. Glyoxalase activity was inhibited by the specific inhibitor CS-0683 and siRNA. The relevance of glyoxalase 1 mRNA abundance on survival of breast cancer patients was evaluated by the KM-plotter web interface.
RESULTS: α-Oxo-aldehydes caused an immediate increase in reactive oxygen species where the tamoxifen resistant cell line (TamR) responded at lower concentrations than the MCF-7 parental cell line. Inhibitor studies placed ROS production by NADPH-oxidase downstream of p38 MAPK. The antioxidant N-acetyl cysteine (NAC) increased survival, whereas glyoxalase (GLO1) inhibition increased dicarbonyl toxicity. GLO1 mRNA abundance was correlated with unfavorable prognosis of breast cancer patients.
CONCLUSIONS: Dicarbonyl toxicity was mediated by oxidative stress and GLO1 activity determines aldehyde toxicity in tamoxifen resistant cells. GENERAL SIGNIFICANCE: Glyoxalases might be predictive biomarkers for tamoxifen resistance and a putative target for the treatment of tamoxifen resistant breast cancer patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glyoxal; Glyoxalase; MAP-kinase signaling; Methylglyoxal; NF-κB; Protein kinase B (AKT); Reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2016        PMID: 26971627     DOI: 10.1016/j.bbagen.2016.03.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact.

Authors:  Martin Porsch; Esra Özdemir; Martin Wisniewski; Sebastian Graf; Fabian Bull; Katrin Hoffmann; Atanas Ignatov; Johannes Haybaeck; Ivo Grosse; Thomas Kalinski; Norbert Nass
Journal:  RNA Biol       Date:  2019-03-05       Impact factor: 4.652

2.  Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases.

Authors:  Norbert Nass; Atanas Ignatov; Ludwig Andreas; Christine Weißenborn; Thomas Kalinski; Saadettin Sel
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

3.  Modulation of GLO1 Expression Affects Malignant Properties of Cells.

Authors:  Antje Hutschenreuther; Marina Bigl; Nasr Y A Hemdan; Tewodros Debebe; Frank Gaunitz; Gerd Birkenmeier
Journal:  Int J Mol Sci       Date:  2016-12-18       Impact factor: 5.923

Review 4.  Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update.

Authors:  Carmen W H Chan; Bernard M H Law; Winnie K W So; Ka Ming Chow; Mary M Y Waye
Journal:  Int J Mol Sci       Date:  2017-11-15       Impact factor: 5.923

5.  Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter.

Authors:  Yueming Zhu; Xianghui Zou; Angela E Dean; Joseph O' Brien; Yucheng Gao; Elizabeth L Tran; Seong-Hoon Park; Guoxiang Liu; Matthew B Kieffer; Haiyan Jiang; Melissa E Stauffer; Robert Hart; Songhua Quan; Karla J F Satchell; Nobuo Horikoshi; Marcelo Bonini; David Gius
Journal:  Nat Commun       Date:  2019-06-03       Impact factor: 14.919

6.  MnSOD Lysine 68 acetylation leads to cisplatin and doxorubicin resistance due to aberrant mitochondrial metabolism.

Authors:  Yucheng Gao; Yueming Zhu; Elizabeth L Tran; Valerie Tokars; Angela E Dean; Songhua Quan; David Gius
Journal:  Int J Biol Sci       Date:  2021-03-19       Impact factor: 6.580

Review 7.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.